Who owns VYNE THERAPEUTICS INC?
- Ticker: VYNE
- CUSIP Number: 92941v308
Tip: Access positions for across all investors
Analyze quarterly positions in Vyne Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vyne Therapeutics stock
Who bought or sold VYNE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cormorant Asset Management | 1.4M | $3.2M | 100% | Dec 2023 |
|
| Eventide Asset Management | 1.4M | $3.2M | 100% | Dec 2023 |
|
| Citadel Advisors | 1.2M | $2.8M | 100% | Dec 2023 |
|
| Soleus Capital Management | 704k | $1.6M | 100% | Dec 2023 |
|
| DSC Advisors | 697k | $1.6M | 506% | Dec 2023 |
|
| Palo Alto Investors | 445k | $1.0M | 100% | Dec 2023 |
|
| AlphaCentric Advisors | 445k | $1.4M | 100% | Mar 2024 |
|
| Exome Asset Management | 118k | $275k | 100% | Dec 2023 |
|
| Fred Alger Management | 60k | $140k | 100% | Dec 2023 |
|
| Vanguard Group | 50k | $116k | 10% | Dec 2023 |
|
| Millennium Management | 17k | $40k | 100% | Dec 2023 |
|
| Hrt Financial | 10k | $23k | 100% | Dec 2023 |
|
| Us Bancorp | 4.4k | $10k | 0% | Dec 2023 |
|
| Bank of America Corporation | 2.8k | $6.5k | -19% | Dec 2023 |
|
| Royal Bank of Canada | 1.3k | $3.0k | -42% | Dec 2023 |
|
| UBS Group | 846.00 | $2.1k | 360% | Dec 2023 |
|
| Russell Investments | 187.00 | $434.999400 | 0% | Dec 2023 |
|
| Wells Fargo & Company | 172.00 | $399.573200 | 64% | Dec 2023 |
|
| Jpmorgan Chase & Co | 146.00 | $346.750000 | 0% | Dec 2023 |
|
| Steward Partners Investment Advisory | 22.00 | $51.000400 | 0% | Dec 2023 |
|
Who sold out of Vyne Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Federated Investors | Sep 2023 | 127.00 | $513.003800 |